PN

The Pennant Group, Inc.

PNTGHealthcareNASDAQ

Medical Care Facilities · Last scanned Jul 16, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$947.7M
+36.3% YoY
Net Income
$29.6M
+31.1% YoY
EBITDA
$60.8M
+36.9% YoY
Free Cash Flow
$19.1M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 91.6, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 80.7, above 70, stock may be overbought
About The Pennant Group, Inc.

Headquartered within the healthcare sector, The Pennant Group, Inc. focuses on Medical Care Facilities services and products. The Pennant Group, Inc. provides healthcare services in the United States. The company carries a $1.39B market cap, placing it firmly in the small-cap category. It operates in two segments, Home Health and Hospice Services, and Senior Living Services.

Key stats
Market Cap$1.39B
P/E (TTM)46.59
Fwd P/E25.07
EPS$0.86
Beta1.25
52W Change+68.6%
ROE10.0%
Analysis

The company holds $4.9M in cash, though total debt stands at $454.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $19.1M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 10.0% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $439.7M (2021) to $947.7M (2025), reflecting a 116% increase over the period.

Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for The Pennant Group, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms